Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

11 Maryn McKenna - Our Scary Post-Antibiotic Future

11 Maryn McKenna - Our Scary Post-Antibiotic Future

FromInquiring Minds


11 Maryn McKenna - Our Scary Post-Antibiotic Future

FromInquiring Minds

ratings:
Length:
55 minutes
Released:
Dec 6, 2013
Format:
Podcast episode

Description

It's flu season. And we're all about to crisscross the country to exchange hugs, kisses and germs. We're going to get sick. And when we do, many of us will run to our doctors and, hoping to get better, demand antibiotics.
And that's the problem: Antibiotics don't cure the flu (which is viral, not bacterial), but the over-prescription of antibiotics imperils us all by driving antibiotic resistance. This threat is growing, so much so that in a recent widely read Medium article, Wired science blogger and self-described "scary disease girl" Maryn McKenna painted a disturbingly plausible picture of a world in which antibiotics have become markedly less effective. That future is the focus of the interview in this week's show.
This episode also features a discussion of the surprising reasons that US students are so bad at math (just 26th in the world, in a recent study). Plus, Indre takes apart a highly controversial new study purporting to show that male-female gender stereotypes are rooted in different wiring of our brains.
Subscribe:
itunes.apple.com/us/podcast/inquiring-minds/id711675943
feeds.feedburner.com/inquiring-minds
Released:
Dec 6, 2013
Format:
Podcast episode

Titles in the series (100)

Each week Inquiring Minds brings you a new, in-depth exploration of the space where science, politics, and society collide.We’re committed to the idea that making an effort to understand the world around you though science and critical thinking can benefit everyone—and lead to better decisions. We endeavor to find out what’s true, what’s left to discover, and why it all matters with weekly coverage of the latest headlines and probing discussions with leading scientists and thinkers.